Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (CB1) receptor ligands
Details for Australian Patent Application No. 2007239102 (hide)
International Classifications
Event Publications
23 October 2008 PCT application entered the National Phase
PCT publication WO2007/120101 Priority application(s): WO2007/120101
7 July 2011 Application Accepted
Published as AU-B-2007239102
11 August 2011 Corrigenda
Applications Accepted - Name Index Under the name AstraZeneca AB, Application No. 2007239102; under INID (72) correct the co-inventors name to Qudoumi, Zena
3 November 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser